Michael Byrnes, CFO and Treasurer at Ocera Therapeutics, Inc. (OCRX), bought 3,000 shares at $1.28 ($4K) on 2017-03-28, disclosed to the SEC on 2017-03-28.
Open-market purchase of $4k OCRX by CFO and Treasurer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| OCRX | BUY | 2015-05-06 | $9K | — | Filing → |
| OCRX | BUY | 2014-10-02 | $10K | — | Filing → |